Does Vitamin D Modulate Asymmetric Dimethylarginine and C-Reactive Protein Concentrations?

American Journal of Medicine

Volumn 123, Issue 4, 2010, Pages 335-341

  Ngo, Doan T ^a,b   Sverdlov, Aaron L ^b   McNeil, John J ^c   Horowitz, John D ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Asymmetric dimethylarginine; Cardiovascular risk; Endothelial dysfunction; High sensitivity C reactive protein; Vitamin D

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CALCIFEDIOL; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; N(G),N(G) DIMETHYLARGININE;

ADULT; AGED; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CORONARY RISK; ENDOTHELIAL DYSFUNCTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEASONAL VARIATION; VITAMIN BLOOD LEVEL;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARGININE; C-REACTIVE PROTEIN; CALCIFEDIOL; CALCIUM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ANGIOTENSIN; SEASONS; SEX CHARACTERISTICS; VITAMIN D;

EID: 77950240732     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.09.024     Document Type: Article

References (42)

1. Hollick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
2. Zitterman A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92 (2006) 39-48
3. Veldman C.M., Cantorna M.T., and DeLuca H.F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374 (2000) 334-338
4. Bouillon R., Carmeliet G., Verlinden L., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29 (2008) 726-776
5. Lemmila S., Saha H., Virtanen V., et al. Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol 18 (1998) 404-410
6. 3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 97 (1996) 1577-1588
7. 3 users in a haemodialysis population. Nephrol Dial Transplant 19 (2004) 179-184
8. Scragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol 10 (1981) 337-341
9. Zipes D.P. Warning: the short days of winter may be hazardous to your health. Circulation 100 (1999) 1590-1592
10. Mortimer Jr. E.A., Monson R.R., and MacMahon B. Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med 296 (1977) 581-585
11. Fabsitz R., and Feinleib M. Geographic patterns in county mortality rates from cardiovascular diseases. Am J Epidemiol 111 (1980) 315-328
12. Talmor Y., Bernheim J., Klein O., et al. Calcitriol blunts pro-atherosclerotic parameters through NFkappa B and p38 in vitrol. Eur J Clin Invest 38 (2008) 548-554
13. Aihara K., Azuma H., Akaike M., et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 279 (2004) 35798-35802
14. London G.M., Guerin A.P., Verbeke F.H., et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18 (2007) 613-620
15. Sugden J.A., Davies J.I., Witham M.D., et al. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25 (2008) 320-325
16. Sydow K., and Munzel T. ADMA and oxidative stress. Atheroscler Suppl 4 (2003) 41-51
17. Boger R.H., Bode-Boger S.M., Thiele W., et al. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95 (1997) 2068-2074
18. Boger R.H. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 59 (2003) 824-833
19. Sabatine M.S., Morrow D.A., Jablonski K.A., et al. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115 (2007) 1528-1536
20. Ridker P.M. The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP?. Arterioscler Thromb Vasc Biol 28 (2008) 1222-1224
21. Zoccali C., Maas R., Cutrupi S., et al. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant 22 (2007) 801-806
22. Grant J.F., Chittleborough C.R., Taylor A.W., et al. The North West Adelaide Health Study: detailed methods and baseline segmentation of a cohort for selected chronic diseases. Epidemiol Perspect Innov 3 (2006) 4
23. Ngo D.T., Sverdlov A.L., Willoughby S.R., et al. Determinants of occurrence of aortic sclerosis in an aging population. J Am Coll Cardiol Img 2 (2009) 919-927
24. Devereux R.B., Lutas E.M., Casale P.N., et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 4 (1984) 1222-1230
25. McEniery C.M., Wallace S., Mackenzie I.S., et al. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 48 (2006) 602-608
26. Heresztyn T., Worthley M.I., and Horowitz J.D. Determination of l-arginine and NG, NG - and NG, NG′ -dimethyl-L-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives. J Chromatogr B Analyt Technol Biomed Life Sci 805 (2004) 325-329
27. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168 (2008) 1340-1349
28. Norman A.W., Bouillon R., Whiting S.J., et al. 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103 (2007) 204-205
29. Tai K., Need A.G., Horowitz M., and Chapman I.M. Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition 24 (2008) 279-285
30. Horowitz J.D., and Heresztyn T. An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations. J Chromatogr B Analyt Technol Biomed Life Sci 851 (2007) 42-50
31. Schnabel R., Blankenberg S., Lubos E., et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97 (2005) e53-e59
32. Martins D., Wolf M., Pan D., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167 (2007) 1159-1165
33. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 (2008) 503-511
34. Giovannucci E., Liu Y., Hollis B.W., and Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168 (2008) 1174-1180
35. Valkonen V.P., Paiva H., Salonen J.T., et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358 (2001) 2127-2128
36. Talmor Y., Golan E., Benchetrit S., et al. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 294 (2008) F1059-F1064
37. Aihara K., Azuma H., Akaike M., et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 279 (2004) 35798-35802
38. London G.M., Guerin A.P., Verbeke F.H., et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18 (2007) 613-620
39. Li Y.C., Kong J., Wei M., et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110 (2002) 229-238
40. Forman J.P., Curhan G.C., and Taylor E.N. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 52 (2008) 828-832
41. Cushman M., Arnold A.M., Psaty B.M., et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 112 (2005) 25-31
42. 3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 65 (2006) 593-597